Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab. [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study to evaluate the safety and tolerability of X/T+X-EC in participants with Alzheimer's disease who are curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lecanemab (lecanemab)
• X/T+X-EC (X/T+X-EC)

Snippet

Sponsor: Neurology Office of South Florida | Conditions: Alzheimers Disease | Phase 2 | Status: NOT_YET_RECRUITING